OpenAI acquires Orchestra Bio
AI Summary
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Discussion
Sign in to join the discussion.
Loading comments…